Bookmarks
Systemic Anti-Cancer Treatment (SACT) data for CPRD Aurum
Population Size
3,255,865
People
Years
2014 - 2018
Associated BioSamples
None/not available
Geographic coverage
United Kingdom
England
Lead time
Variable
Summary
CPRD Aurum linked Systemic Anti-Cancer Treatment (SACT) data contain chemotherapy treatment details, including regime and outcomes, for solid tumour and haematological malignancies treated in England.
DOI for dataset
Documentation
CPRD Aurum linked Systemic Anti-Cancer Treatment (SACT) data cover chemotherapy treatment for all solid tumour and haematological malignancies, including those in clinical trials. Information is included about programme and regime of treatment, and the outcome for each treatment.
Dataset type
Health and disease
Dataset sub-type
Not applicable
Dataset population size
3255865
Associated media
Keywords
Cancer Treatment, SACT
Observations
Observed Node | Disambiguating Description | Measured Value | Measured Property | Observation Date |
|---|---|---|---|---|
Persons | Number of CPRD Aurum patients matched to a single cancer identifier | 3255865 | Count | 06 Sep 2021 |
Provenance
Source of data extraction
EPR
Collection source setting
Clinic, Community, Secondary care - In-patients, Secondary care - Outpatients
Patient pathway description
Cancer registration data are collected from a range of health care provider systems and other services.
Image contrast
Not stated
Biological sample availability
None/not available
Structural Metadata
Details
Publishing frequency
Quarterly
Version
6.0.0
Modified
08/10/2024
Distribution release date
06/09/2021
Citation Requirements
Public Health England (PHE) via the National Cancer Registration and Analysis Service (NCRAS)
Coverage
Start date
01/01/2014
End date
31/12/2018
Time lag
More than 6 months
Geographic coverage
United Kingdom, England
Maximum age range
115
Follow-up
1 - 10 Years
Accessibility
Language
en
Controlled vocabulary
ICD10, ICDO3, OPCS4
Format
Tab delimited text
Data Access Request
Dataset pipeline status
Not available
Access rights
Time to dataset access
Variable
Access request cost
Access method category
Varies based on project
Access service description
Access to CPRD data, including UK Primary Care Data, and linked data such as Hospital Episode Statistics, is subject to protocol approval via CPRD’s Research Data Governance (RDG) Process. Independent scientific and patient advice is provided by Expert Review Committees (ERCs) and the Central Advisory Committee (CAC): https://www.cprd.com/research-applications
Jurisdiction
GB-ENG
Data use limitation
General research use,No linkage,Research-specific restrictions,Research use only
Data use requirements
Geographical restrictions,Institution-specific restrictions,Project-specific restrictions,Time limit on use,User-specific restriction
Data Controller
Clinical Practice Research Datalink (CPRD)
Data Processor
CPRD